Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS), Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2025-2033

Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS), Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4297

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Irritable Bowel Syndrome Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    IBS with Diarrhea (IBS-D)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    IBS with Constipation (IBS-C)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Mixed IBS
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Product
    7.1    Rifaximin
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Eluxadoline
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Lubiprostone
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Linaclotide
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospitals Pharmacies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Drug Stores and Retail Pharmacies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Stores
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Allergan plc (AbbVie Inc.)
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Ardelyx Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Astellas Pharma Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    AstraZeneca plc
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Bausch Health Companies Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    GlaxoSmithKline Plc
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Novartis AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Sebela Pharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Synthetic Biologics Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis

List of Figures

​Figure 1: Global: Irritable Bowel Syndrome Treatment Market: Major Drivers and Challenges
Figure 2: Global: Irritable Bowel Syndrome Treatment Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Type (in %), 2024
Figure 5: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Product (in %), 2024
Figure 6: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Irritable Bowel Syndrome Treatment Market: Breakup by Region (in %), 2024
Figure 8: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Irritable Bowel Syndrome Treatment (IBS with Diarrhea (IBS-D)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Irritable Bowel Syndrome Treatment (IBS with Constipation (IBS-C)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Irritable Bowel Syndrome Treatment (Mixed IBS) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Irritable Bowel Syndrome Treatment (Rifaximin) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Irritable Bowel Syndrome Treatment (Eluxadoline) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Irritable Bowel Syndrome Treatment (Lubiprostone) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Irritable Bowel Syndrome Treatment (Linaclotide) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Irritable Bowel Syndrome Treatment (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Irritable Bowel Syndrome Treatment (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Irritable Bowel Syndrome Treatment (Hospitals Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Irritable Bowel Syndrome Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Irritable Bowel Syndrome Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: North America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: North America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: United States: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: United States: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Canada: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Canada: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Asia-Pacific: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Asia-Pacific: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: China: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: China: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Japan: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Japan: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: India: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: India: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: South Korea: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: South Korea: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Australia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Australia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Indonesia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Indonesia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Europe: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Europe: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Germany: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Germany: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: France: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: France: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: United Kingdom: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: United Kingdom: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Italy: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Italy: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Spain: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Spain: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Russia: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Russia: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Latin America: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Latin America: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Brazil: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Brazil: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Mexico: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Mexico: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Middle East and Africa: Irritable Bowel Syndrome Treatment Market: Breakup by Country (in %), 2024
Figure 78: Middle East and Africa: Irritable Bowel Syndrome Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Global: Irritable Bowel Syndrome Treatment Industry: SWOT Analysis
Figure 80: Global: Irritable Bowel Syndrome Treatment Industry: Value Chain Analysis
Figure 81: Global: Irritable Bowel Syndrome Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 4: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Irritable Bowel Syndrome Treatment Market: Competitive Structure
Table 7: Global: Irritable Bowel Syndrome Treatment Market: Key Players

Irritable Bowel Syndrome Treatment Market Report by Type (IBS with Diarrhea (IBS-D), IBS with Constipation (IBS-C), Mixed IBS), Product (Rifaximin, Eluxadoline, Lubiprostone, Linaclotide, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials